Key Charpentier/Doudna CRISPR patent upheld by China National Intellectual Property Administration

RS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, today announced its patent CN201380038920.6 was upheld by the CNIPA in response to an invalidation challenge.

Breakthrough microscopy technique reveals how antibodies target cancer cells

In blood cancers such as chronic lymphocytic leukaemia, B cells of the immune system multiply uncontrollably.

January 10, 2025

Opinion | The Real Forces That Motivate Us in Healthcare

Lazarus is an adjunct professor of psychiatry. Various metaphysical concepts — those that transcend physical explanations or rules — have influenced the field of medicine

April 22, 2024

COVID-19’s impact on maternal mortality demands rethink of public health strategies

During the peak of the SARS-CoV-2 pandemic, there was an increase in maternal mortality in Chile. This is confirmed by a natural population experiment based

July 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.